AIM

AIM ImmunoTech Inc.

21 hedge funds and large institutions have $1.53M invested in AIM ImmunoTech Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$472K 942,011 -228,782 -20%
AFM
2
Anson Funds Management
Texas
$462K 924,563 +924,563 New
BlackRock
3
BlackRock
New York
$230K 460,698 -33,248 -7%
Vanguard Group
4
Vanguard Group
Pennsylvania
$227K 453,805 +2,709 +0.6%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$37K 74,832
Renaissance Technologies
6
Renaissance Technologies
New York
$36K 71,952 -61,600 -46%
Creative Planning
7
Creative Planning
Kansas
$20K 40,001 -5 -0%
Northern Trust
8
Northern Trust
Illinois
$16K 31,933
Bank of New York Mellon
9
Bank of New York Mellon
New York
$13K 26,116 +10,904 +72%
OAM
10
Occidental Asset Management
California
$8K 15,834
GC
11
Guggenheim Capital
Illinois
$6K 12,780
WPW
12
Waldron Private Wealth
Pennsylvania
$5K 11,000
UBS Group
13
UBS Group
Switzerland
$1K 2,581 -7,094 -73%
Morgan Stanley
14
Morgan Stanley
New York
$1K 1,084
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
-41,046 Closed
PAM
16
Panagora Asset Management
Massachusetts
-26,251 Closed
LTFS
17
Ladenburg Thalmann Financial Services
Florida
$0 80
Wells Fargo
18
Wells Fargo
California
$0 417
JCM
19
Jacobi Capital Management
Pennsylvania
$0 55
AG
20
Advisor Group
Arizona
$0 250
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$0 216
Deutsche Bank
22
Deutsche Bank
Germany
$0 24
CHC
23
City Holding Co
West Virginia
$0 417